Compare Emerson Electric Co. (EMR) vs Freeport-McMoRan Inc (FCX) Price & Performance

Emerson Electric (EMR) trades at $164.19, down slightly by 0.11% on the day, with a bullish technical outlook as it hovers near pivot point resistance. The company reported strong Q2 2026 earnings, beating EPS estimates with $1.71 versus $1.68 expected, driven by 7% revenue growth and robust performance in Software & Systems. Recent acquisitions and AI initiatives, such as the Glue Inc. purchase, highlight strategic expansion. Valuation ratios like a P/E of 35.84 and P/S of 4.95 reflect premium pricing amid solid profitability, with a net income margin of 13.83%.

EMR's outlook is positive, supported by raised 2026 guidance and analyst consensus favoring a buy rating with a $171.33 price target. Key opportunities include organic growth in automation and AI integration, but risks involve high valuation sensitivity and macroeconomic pressures on industrial demand. Cash flow volatility from recent net outflows requires monitoring for sustainability.

FCX trades at $66.83, down 2.98% on the day, but maintains a bullish technical trend with strong analyst support. The company has beaten earnings estimates for three consecutive quarters, with Q3 2026 expected at $0.72 EPS. Revenue remains stable around $25.9B, while net income margin improved to 11.38% in 2026. Recent news highlights operational challenges like lower copper volumes but also growth initiatives at Grasberg and Bagdad.

The outlook is positive with a consensus price target of $73.85, implying ~10% upside. Key opportunities include exposure to high copper prices and expansion projects, while risks involve production volatility, cost pressures, and reliance on commodity cycles. The stock's valuation appears elevated with a P/E of 33.93, requiring sustained earnings growth to justify further gains.